Meaningful Use Assessment

Meaningful Use Assessments can help companies develop a roadmap with clear steps.  The HITECH Act provides incentives for Medicare and Medicaid providers to achieve Meaningful Use of Electronic Medical Records.  The Meaningful Use Assessment may include these phases and components:

  • Meaningful Use Project Governance
  • Meaningful Use rapid assessment of the current organization and requirements
  • Meaningful Use Business Case and Return on Investment (ROI)
  • Meaningful Use Executive and Stakeholder Awareness training
  • Meaningful Use Business road map development for Stage 1 and Stage 2 to clearly define opportunities and priorities
  • Meaningful Use Stage 3 – understanding patient engagement
  • Meaningful Use specialty medicine / specialty practice approaches for Radiology, Oncology, Cardiology, Orthopedics and other practice areas.
  • Meaningful Use quality measure benefits awareness training
  • Meaningful Use Interoperability Assessment based on HHS ONC standards
  • Meaningful Use in-depth Training
  • Meaningful Use High-level review and skills inventory
  • Meaningful Use In-Depth Assessment and ICD-10 Gap Analysis
  • Implementation Planning & Design
  • Electronic Medical Record vendor selection, vendor assessment, and contract reviews
  • Clinical Documentation Improvement with Electronic Medical Records
  • Synergies with ICD-10
  • Data migration planning
  • Vendor requirements for Ambulatory, or Inpatient per section 170.302
  • Security and privacy assessment per section 170.302
  • Implementation
  • Selection of a vendor that has been certified by an Authorized Testing and Certification Body (ATCB)
  • Vendor Readiness Assessments
  • Business Test Plan Review

MU impacts these organizations:

  • Hospitals (including Inpatient and Acute Care, Community Access Hospitals, Academic Medical Centers & Federally Qualified Rural Health Centers)
  • Clinics (both stand alone and those affiliated with hospitals)
  • Physicians (private Physician practices, IPAs and other groups including specialty practices in Oncology, Gastroenterology, Nephrology, Obstetrics and Gynecology, Primary Care/Family Physicians.
  • Self-insured employers considering the benefits of Accountable Care Organizations
  • Patients
  • Vendors of Electronic Medical Records or Electronic Health Records Systems, Computerized Physician Order Entry (CPOE) and other modules
  • Service Providers who deliver information to the health care services industry, especially if information contains Personal Health Information (PHI)
  • Health plans that are interested in reducing costs of acquiring medical records for utilization and case management without using faxes and paper.
  • Regulatory Agencies

If you are preparing a Request for Proposal or are interested in our detail Meaningful Use Assessment Methodology, our nationally recognized experts and consulting team can help.

Related Posts

Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See and for more about the company.

Leave a Reply